Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Indantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 430.00 | |
10 mg | In stock | $ 636.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,360.00 | |
100 mg | In stock | $ 1,830.00 | |
500 mg | In stock | $ 3,680.00 |
Description | Indantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor. |
In vivo | In a human heat-capsaicin-induced pain model, Indantadol HCl at a dose of 500 mg effectively reduced the area of secondary hyperalgesia to 67%. Indantadol HCl undergoes extensive liver metabolism, withthe formation of two major metabolites - CHF-3567 and 2-aminoindane. The drug is excreted in urine partially as the parent compound, but mostly as CHF-3567. The tolerability profile of Indantadol HCl at single doses up to 600 mg and twice-daily doses up to 400 mg in clinical trials was significantly more favorable than for other NMDA antagonists. Most side effects have been observed to be mild, and include dizziness and asthenia. Indantadol HCl is currently in phase II clinical trials in patients with diabetic peripheral neuropathic pain.[1] |
Synonyms | CHF-3381, CMP-3381, GT-3381, V-3381, CNP-3381, Indantadol |
Molecular Weight | 226.7 |
Formula | C11H15ClN2O |
CAS No. | 202914-18-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Indantadol HCl 202914-18-9 Metabolism Neuroscience MAO NMDAR CNP3381 CHF 3381 GT3381 CMP3381 CHF-3381 V3381 CMP 3381 CMP-3381 CNP 3381 GT-3381 GT 3381 CHF3381 V-3381 CNP-3381 V 3381 Indantadol inhibitor inhibit